AVNS Avanos Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AVNS

Price (delayed)

$29.09

Market cap

$1.36B

P/E Ratio

26.94

Dividend/share

N/A

EPS

$1.08

Enterprise value

$1.51B

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
The gross profit has grown by 23% YoY and by 4.4% from the previous quarter
The EPS has grown by 15% from the previous quarter
Avanos Medical's debt has increased by 49% YoY but it has decreased by 8% from the previous quarter
The quick ratio has declined by 11% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://avanos.com/

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
46.6M
Market cap
$1.36B
Enterprise value
$1.51B
Valuations
Price to earnings (P/E)
26.94
Price to book (P/B)
1.05
Price to sales (P/S)
1.65
EV/EBIT
20.05
EV/EBITDA
12.27
EV/Sales
1.84
Earnings
Revenue
$820M
EBIT
$75.2M
EBITDA
$122.9M
Free cash flow
$71.6M
Per share
EPS
$1.08
Free cash flow per share
$1.54
Book value per share
$27.77
Revenue per share
$17.64
TBVPS
$15.41
Balance sheet
Total assets
$1.79B
Total liabilities
$495.7M
Debt
$280M
Equity
$1.29B
Working capital
$314M
Liquidity
Debt to equity
0.22
Current ratio
2.69
Quick ratio
1.59
Net debt/EBITDA
1.24
Margins
EBITDA margin
15%
Gross margin
54.9%
Net margin
6.2%
Operating margin
9.5%
Efficiency
Return on assets
2.9%
Return on equity
4%
Return on invested capital
10.6%
Return on capital employed
4.7%
Return on sales
9.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
-1.39%
1 week
4.38%
1 month
-0.14%
1 year
-10.41%
YTD
7.5%
QTD
7.5%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$820M
Gross profit
$450M
Operating income
$77.5M
Net income
$50.5M
Gross margin
54.9%
Net margin
6.2%
The operating income has soared by 133% YoY and by 18% QoQ
Avanos Medical's operating margin has soared by 111% YoY and by 14% from the previous quarter
The gross profit has grown by 23% YoY and by 4.4% from the previous quarter
The net income has increased by 14% from the previous quarter

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
P/E
26.94
P/B
1.05
P/S
1.65
EV/EBIT
20.05
EV/EBITDA
12.27
EV/Sales
1.84
The EPS has grown by 15% from the previous quarter
AVNS's price to book (P/B) is 24% less than its 5-year quarterly average of 1.4 but 6% more than its last 4 quarters average of 1.0
The company's equity rose by 2.2% QoQ
The P/S is 36% lower than the 5-year quarterly average of 2.6 but 4.4% higher than the last 4 quarters average of 1.6
The revenue is up by 10% year-on-year and by 3% since the previous quarter

Efficiency

How efficient is Avanos Medical business performance
The ROE has grown by 14% from the previous quarter
The return on assets has increased by 12% since the previous quarter
AVNS's ROIC is down by 2.8% from the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
Avanos Medical's total liabilities has increased by 49% YoY but it has decreased by 3.1% from the previous quarter
The company's current ratio fell by 12% YoY and by 7% QoQ
Avanos Medical's debt is 78% less than its equity
Avanos Medical's debt has increased by 49% YoY but it has decreased by 8% from the previous quarter
The debt to equity has grown by 47% YoY but it has contracted by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.